Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Fibroblastic Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Mesenchymal Cell Neoplasm
Fibroblastic Neoplasm

Cancer Family

Fibroblastic Neoplasm

CI-CAN-00000181Explore in graph →

Non-malignant45 active trials52 evidence items

NCIt: C7075

Overview
Statistics
Survival
Genomics
Variants & evidence52
Drugs6
Trials203
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (35)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 26–35 of 35 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib.
· Cold Spring Harb Mol Case Stud · 2019 · PMID 30709876 · validated civic_curation pubmed
Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
· Mod Pathol · 2018 · PMID 29099503 · validated civic_curation pubmed
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
· Ann Oncol · 2019 · PMID 32223937 · validated civic_curation pubmed
Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma.
· Cold Spring Harb Mol Case Stud · 2015 · PMID 27148571 · validated civic_curation pubmed
Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
· Am J Surg Pathol · 2014 · PMID 24441665 · validated civic_curation pubmed
A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
· Genes Chromosomes Cancer · 2015 · PMID 25231134 · validated civic_curation pubmed
COL1A1-PDGFB fusion in a pediatric Bednar tumor with 2 copies of a der(22)t(17;22).
· Cancer Genet Cytogenet · 2006 · PMID 16843106

Showing 26–35 of 35 publications

← Previous
1
2
Next →

· validated civic_curation

CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.

· PLoS One · 2014 · PMID 24788118 · validated civic_curation pubmed

Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101.

· Pediatr Blood Cancer · 2016 · PMID 27093299 · validated civic_curation pubmed

CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.

· Mol Cancer Ther · 2015 · PMID 25852058 · validated civic_curation pubmed